RNS Number : 2890N
Marks & Spencer Group PLC
16 January 2019
 

Director/PDMR Shareholding

Marks and Spencer Group plc (the 'Company') announces that it has been notified of the following transactions in the Company's Ordinary 25p shares undertaken by directors / persons discharging managerial responsibility ('PDMRs').

On 11 January 2018, the following directors / PDMRs acquired a further interest in the Company's shares as a result of their participation in the Company's Dividend Reinvestment Plan (DRIP).

Name

 

Number of Shares Acquired

 

Share Price (£)

S Berendji

1,538

2.761


The notifications set out below are provided in accordance with the requirements of Article 19 of the EU Market Abuse Regulation.

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

S Berendji

2

Reason for the notification

a)

Position/status

PDMR (Director of Retail)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Marks and Spencer Group plc

b)

LEI

213800EJP14A79ZG1X44

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary 25p shares

 

ISIN: GB0031274896

b)

Nature of the transaction

Acquisition of Shares through the Company's Dividend Reinvestment Plan (DRIP)

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£2.761

 1,532

£2.761

6

d)

Aggregated information

-

Aggregated volume

-

Price

 

1,538

£4,246.41

e)

Date of the transaction

2019-01-11

f)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHXQLFFKFFBBBZ